+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Retinal Imaging Devices Market (2019-2025)

  • PDF Icon

    Report

  • 170 Pages
  • January 2020
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 4987684
Description Jump to:
The Global Retinal Imaging Devices Market size is expected to reach6.3 billion by 2025, rising at a market growth of 6.6% CAGR during the forecast period. Retinal imaging devices help eye care professionals identify, assess, document, and treat retinal disorders. The advanced retinal imaging devices can view the retina by a single capture up to 0 to 200 degrees. In traditional devices, full-spectrum white light is used; however, advanced retinal imaging devices use low-powered laser light. Retinal imaging takes a digital photograph to the back of the eye. It shows the retina (where light and objects hit), the optic disk (a location on the retina that houses the optic nerve, transmitting data to the brain), and the blood vessels. It helps to find out optometrist or ophthalmologist illnesses and to check the health of the eyes.

The global market for retinal imaging products is driven primarily by an increase in the prevalence of retinal disorders worldwide, high rates of diagnosis and treatment of retinal disorders, advances in technology, and improved health care infrastructure. Nonetheless, the market is expected to be regulated by strict regulatory frameworks and intellectual property rights laws. In the coming years, mergers and acquisitions among leading players and an escalation in R&D investments are projected to drive the global market for retinal imaging devices.

Highly developed health care, strong research, and development system and a rise in retinal disorders are the prominent factors that contributed to a dominant market share of Germany, France, and the United Kingdom in the European region. In 2017, China and Japan retained large shares of the market for retinal imaging devices in the Asia Pacific. The market in India is likely to expand at a fast CAGR in the near future due to the developing health care industry and the involvement of well-established domestic players. The underdeveloped health care industry and less technological progress are expected to hinder the growth of the market for retinal imaging devices in Latin America and the Middle East and Africa during the forecast period.

Based on Type, the market is segmented into Fundus Camera, Fluorescein Angiography and OCT (Optical Coherence Tomography). Based on End Use, the market is segmented into Hospitals, Ophthalmic Centers, ASCs (Ambulatory Surgery Centers) and Other End Use. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The major strategies followed by the market participants are Product launches. Based on the Analysis presented in the Cardinal matrix, Robert Bosch GmbH (Bosch Healthcare) is the major forerunner in the Retinal Imaging Devices Market. The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Topcon Corporation, Carl Zeiss AG, Olympus Corporation, Robert Bosch GmbH (Bosch Healthcare), Revenio Group Oyj (CenterVue SpA), Nikon Corporation (Optos PLC), Optomed PLC, Epipole Ltd., Nidek Co., Ltd., and Eyenuk, Inc.

Recent strategies deployed in Retinal Imaging Devices Market

Partnerships, Collaborations, and Agreements:

Sep-2019: Zeiss Vision Care US and Zeiss Medical Technology signed a five-year agreement with IDOC. In this agreement, they aimed at bringing ZEISS’ industry-leading lab services, medical equipment, and lens products to all the 3,000+ IDOC independent optometrists across the US.

Oct-2018: Optos, a Nikon Company signed an agreement with Amydis. The agreement was focused on developing an eye test by Amydis to detect Alzheimer’s disease. The partnership has integrated Amydis’ first in class, proprietary compounds with Optos’ market leadership with its proprietary ultra-widefield technology and strong commercial presence among eyecare specialists for expanding the market opportunity.

Oct-2018: Optos, a subsidiary of Nikon signed distribution agreement with Europe and Australia for MacuLogix and LumiThera products. Through this agreement, the company provides a comprehensive solution for identifying, visualizing, and treating the age-related macular degeneration (AMD), a leading cause of blindness in world.

Oct-2018: Topcon announced an agreement with IDx for selling the artificial intelligence-based diagnostic systems of IDx with Topcon NW400 robotic fundus camera.

Acquisition and Mergers:

Mar-2018: Optomed acquired Commit Oy; a company specialized in healthcare software solutions. The acquisition helped the former company in offering complete and proven solutions for screening of diabetic retinopathy and other diseases.

Geographical Expansions:

Oct-2018: Eyenuk expanded its reach to Germany by adopting EyeArt® artificial intelligence (AI) technology for screening of diabetic retinopathy at Diabetes Center Mergentheim in Bad Mergentheim, Germany.

Product Launches and Product Expansions:

Oct-2019: Optos, a Nikon Company launched Silverstone, first-of-its-kind that combines ultra-widefield retinal imaging with integrated; image-guided, swept source OCT. The device produces a 200° single capture optomap image with guided OCT, enabling advanced OCT imaging anywhere across the retina, from posterior pole to far periphery.

Aug-2019: Topcon launched Maestro2 Automated OCT/Fundus Camera with OCTA. It is a fully-automated OCT system that has the capability to capture high resolution non-mydriatic, true color fundus photography, OCTA, and OCT with the single push of a button.

Aug-2019: Nidek introduced Mirante Scanning Laser Ophthalmoscope. It is an ultimate multimodal fundus imaging platform, which integrates high definition OCT and SLO with ultra-wide field imaging. It captures fluorescein angiography (FA), high quality color images, ndocyanine green angiography (ICG), unique Retro mode images, fundus autofluorescence (FAF), OCT-Angiography, and OCT scan.

Jun-2019: Olympus launched 2X teleconverter, the MC-20, compatible with company's 40-150 F2.8 and 300mm F4 IS Pro lenses. It doubles the focal length of master lens and is dustproof, freezeproof, and splashproof.

May-2019: Zeiss unveiled ARTEVO 800, first digital microscope in opthalmic surgery. It features DigitalOptics technology for providing reduced light intensity requirements, depth of field, and real color impression for increased certainty.

Feb-2019: Optomed made enhancements to its Optomed Aurora camera. The new features include faster and smarter autofocus, image quality analysis, and four image sequences, new ways of selecting patient list, and optimized target led selection.

Sep-2018: Optos, a part of Nikon introduced Monaco, its latest ultra-widefield device for European ophthalmic market. It is the only ultra-widefield retinal imaging system with integrated Optical Coherence Tomography (OCT). The device generates 200° single-capture optomap image in less than half a second.

Scope of the Study

Market Segmentation:

By Type
  • Fundus Camera
  • Fluorescein Angiography
  • OCT (Optical Coherence Tomography)

By End Use
  • Hospitals
  • Ophthalmic Centers
  • ASCs (Ambulatory Surgery Centers)
  • Other End Use

By Geography

North America
  • US
  • Canada
  • Mexico
  • Rest of North America

Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia
  • Rest of Asia Pacific

LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled
  • Topcon Corporation
  • Carl Zeiss AG
  • Olympus Corporation
  • Robert Bosch GmbH (Bosch Healthcare)
  • Revenio Group Oyj (CenterVue SpA)
  • Nikon Corporation (Optos PLC)
  • Optomed PLC
  • Epipole Ltd.
  • Nidek Co., Ltd.
  • Eyenuk, Inc.

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Retinal Imaging Devices Market, by Type
1.4.2 Global Retinal Imaging Devices Market, by End Use
1.4.3 Global Retinal Imaging Devices Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Market Analysis
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2019-Oct - 2015-Jan) Leading Players
Chapter 4. Global Retinal Imaging Devices Market by Type
4.1 Global Fundus Camera Market by Region
4.2 Global Fluorescein Angiography Market by Region
4.3 Global OCT Market by Region
Chapter 5. Global Retinal Imaging Devices Market by End-Use
5.1 Global Hospitals Market by Region
5.2 Global Ophthalmic Centers Market by Region
5.3 Global ASCs Market by Region
5.4 Global Other End-Use Market by Region
Chapter 6. Global Retinal Imaging Devices Market by Region
6.1 North America Retinal Imaging Devices Market
6.1.1 North America Retinal Imaging Devices Market by Type
6.1.1.1 North America Fundus Camera Market by Country
6.1.1.2 North America Fluorescein Angiography Market by Country
6.1.1.3 North America OCT Market by Country
6.1.2 North America Retinal Imaging Devices Market by End-Use
6.1.2.1 North America Hospitals Market by Country
6.1.2.2 North America Ophthalmic Centers Market by Country
6.1.2.3 North America ASCs Market by Country
6.1.2.4 North America Other End-Use Market by Country
6.1.3 North America Retinal Imaging Devices Market by Country
6.1.3.1 USA Retinal Imaging Devices Market
6.1.3.1.1 USA Retinal Imaging Devices Market by Type
6.1.3.1.2 USA Retinal Imaging Devices Market by End-Use
6.1.3.2 Canada Retinal Imaging Devices Market
6.1.3.2.1 Canada Retinal Imaging Devices Market by Type
6.1.3.2.2 Canada Retinal Imaging Devices Market by End-Use
6.1.3.3 Mexico Retinal Imaging Devices Market
6.1.3.3.1 Mexico Retinal Imaging Devices Market by Type
6.1.3.3.2 Mexico Retinal Imaging Devices Market by End-Use
6.1.3.4 Rest of North America Retinal Imaging Devices Market
6.1.3.4.1 Rest of North America Retinal Imaging Devices Market by Type
6.1.3.4.2 Rest of North America Retinal Imaging Devices Market by End-Use
6.2 Europe Retinal Imaging Devices Market
6.2.1 Europe Retinal Imaging Devices Market by Type
6.2.1.1 Europe Fundus Camera Market by Country
6.2.1.2 Europe Fluorescein Angiography Market by Country
6.2.1.3 Europe OCT Market by Country
6.2.2 Europe Retinal Imaging Devices Market by End-Use
6.2.2.1 Europe Hospitals Market by Country
6.2.2.2 Europe Ophthalmic Centers Market by Country
6.2.2.3 Europe ASCs Market by Country
6.2.2.4 Europe Other End-Use Market by Country
6.2.3 Europe Retinal Imaging Devices Market by Country
6.2.3.1 Germany Retinal Imaging Devices Market
6.2.3.1.1 Germany Retinal Imaging Devices Market by Type
6.2.3.1.2 Germany Retinal Imaging Devices Market by End-Use
6.2.3.2 UK Retinal Imaging Devices Market
6.2.3.2.1 UK Retinal Imaging Devices Market by Type
6.2.3.2.2 UK Retinal Imaging Devices Market by End-Use
6.2.3.3 France Retinal Imaging Devices Market
6.2.3.3.1 France Retinal Imaging Devices Market by Type
6.2.3.3.2 France Retinal Imaging Devices Market by End-Use
6.2.3.4 Russia Retinal Imaging Devices Market
6.2.3.4.1 Russia Retinal Imaging Devices Market by Type
6.2.3.4.2 Russia Retinal Imaging Devices Market by End-Use
6.2.3.5 Spain Retinal Imaging Devices Market
6.2.3.5.1 Spain Retinal Imaging Devices Market by Type
6.2.3.5.2 Spain Retinal Imaging Devices Market by End-Use
6.2.3.6 Italy Retinal Imaging Devices Market
6.2.3.6.1 Italy Retinal Imaging Devices Market by Type
6.2.3.6.2 Italy Retinal Imaging Devices Market by End-Use
6.2.3.7 Rest of Europe Retinal Imaging Devices Market
6.2.3.7.1 Rest of Europe Retinal Imaging Devices Market by Type
6.2.3.7.2 Rest of Europe Retinal Imaging Devices Market by End-Use
6.3 Asia Pacific Retinal Imaging Devices Market
6.3.1 Asia Pacific Retinal Imaging Devices Market by Type
6.3.1.1 Asia Pacific Fundus Camera Market by Country
6.3.1.2 Asia Pacific Fluorescein Angiography Market by Country
6.3.1.3 Asia Pacific OCT Market by Country
6.3.2 Asia Pacific Retinal Imaging Devices Market by End-Use
6.3.2.1 Asia Pacific Hospitals Market by Country
6.3.2.2 Asia Pacific Ophthalmic Centers Market by Country
6.3.2.3 Asia Pacific ASCs Market by Country
6.3.2.4 Asia Pacific Other End-Use Market by Country
6.3.3 Asia Pacific Retinal Imaging Devices Market by Country
6.3.3.1 China Retinal Imaging Devices Market
6.3.3.1.1 China Retinal Imaging Devices Market by Type
6.3.3.1.2 China Retinal Imaging Devices Market by End-Use
6.3.3.2 India Retinal Imaging Devices Market
6.3.3.2.1 India Retinal Imaging Devices Market by Type
6.3.3.2.2 India Retinal Imaging Devices Market by End-Use
6.3.3.3 Japan Retinal Imaging Devices Market
6.3.3.3.1 Japan Retinal Imaging Devices Market by Type
6.3.3.3.2 Japan Retinal Imaging Devices Market by End-Use
6.3.3.4 Australia Retinal Imaging Devices Market
6.3.3.4.1 Australia Retinal Imaging Devices Market by Type
6.3.3.4.2 Australia Retinal Imaging Devices Market by End-Use
6.3.3.5 South Korea Retinal Imaging Devices Market
6.3.3.5.1 South Korea Retinal Imaging Devices Market by Type
6.3.3.5.2 South Korea Retinal Imaging Devices Market by End-Use
6.3.3.6 Singapore Retinal Imaging Devices Market
6.3.3.6.1 Singapore Retinal Imaging Devices Market by Type
6.3.3.6.2 Singapore Retinal Imaging Devices Market by End-Use
6.3.3.7 Rest of Asia Pacific Retinal Imaging Devices Market
6.3.3.7.1 Rest of Asia Pacific Retinal Imaging Devices Market by Type
6.3.3.7.2 Rest of Asia Pacific Retinal Imaging Devices Market by End-Use
6.4 LAMEA Retinal Imaging Devices Market
6.4.1 LAMEA Retinal Imaging Devices Market by Type
6.4.1.1 LAMEA Fundus Camera Market by Country
6.4.1.2 LAMEA Fluorescein Angiography Market by Country
6.4.1.3 LAMEA OCT Market by Country
6.4.2 LAMEA Retinal Imaging Devices Market by End-Use
6.4.2.1 LAMEA Hospitals Market by Country
6.4.2.2 LAMEA Ophthalmic Centers Market by Country
6.4.2.3 LAMEA ASCs Market by Country
6.4.2.4 LAMEA Other End-Use Market by Country
6.4.3 LAMEA Retinal Imaging Devices Market by Country
6.4.3.1 Brazil Retinal Imaging Devices Market
6.4.3.1.1 Brazil Retinal Imaging Devices Market by Type
6.4.3.1.2 Brazil Retinal Imaging Devices Market by End-Use
6.4.3.2 Argentina Retinal Imaging Devices Market
6.4.3.2.1 Argentina Retinal Imaging Devices Market by Type
6.4.3.2.2 Argentina Retinal Imaging Devices Market by End-Use
6.4.3.3 UAE Retinal Imaging Devices Market
6.4.3.3.1 UAE Retinal Imaging Devices Market by Type
6.4.3.3.2 UAE Retinal Imaging Devices Market by End-Use
6.4.3.4 Saudi Arabia Retinal Imaging Devices Market
6.4.3.4.1 Saudi Arabia Retinal Imaging Devices Market by Type
6.4.3.4.2 Saudi Arabia Retinal Imaging Devices Market by End-Use
6.4.3.5 South Africa Retinal Imaging Devices Market
6.4.3.5.1 South Africa Retinal Imaging Devices Market by Type
6.4.3.5.2 South Africa Retinal Imaging Devices Market by End-Use
6.4.3.6 Nigeria Retinal Imaging Devices Market
6.4.3.6.1 Nigeria Retinal Imaging Devices Market by Type
6.4.3.6.2 Nigeria Retinal Imaging Devices Market by End-Use
6.4.3.7 Rest of LAMEA Retinal Imaging Devices Market
6.4.3.7.1 Rest of LAMEA Retinal Imaging Devices Market by Type
6.4.3.7.2 Rest of LAMEA Retinal Imaging Devices Market by End-Use
Chapter 7. Company Profiles
7.1 Topcon Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Recent strategies and developments:
7.1.4.1 Partnerships, Collaborations, and Agreements:
7.1.4.2 Product Launches and Product Expansions:
7.2 Carl Zeiss AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.5.2 Product Launches and Product Expansions:
7.3 Olympus Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Robert Bosch GmbH (Bosch Healthcare)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Revenio Group Oyj (CenterVue SpA)
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Product Launches and Product Expansions:
7.6 Nikon Corporation (Optos PLC)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segment and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Product Launches and Product Expansions:
7.7 Optomed PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Research & Development Expense
7.7.4 Recent strategies and developments:
7.7.4.1 Product Launches and Product Expansions:
7.7.4.2 Acquisition and Mergers:
7.8 Epipole Ltd.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Partnerships, Collaborations, and Agreements:
7.8.2.2 Product Launches and Product Expansions:
7.9 Nidek Co., Ltd.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Product Launches and Product Expansions:
7.1 Eyenuk, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Geographical Expansions:

Companies Mentioned

  • Topcon Corporation
  • Carl Zeiss AG
  • Olympus Corporation
  • Robert Bosch GmbH (Bosch Healthcare)
  • Revenio Group Oyj (CenterVue SpA)
  • Nikon Corporation (Optos PLC)
  • Optomed PLC
  • Epipole Ltd.
  • Nidek Co., Ltd.
  • Eyenuk, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Global Retinal Imaging Devices Market by Type (Fluorescein Angiography, Fundus Camera, Optical Coherence Tomography), End-User (ASCs, Hospitals, Ophthalmic Centers) - Forecast 2024-2030 - Product Image

Global Retinal Imaging Devices Market by Type (Fluorescein Angiography, Fundus Camera, Optical Coherence Tomography), End-User (ASCs, Hospitals, Ophthalmic Centers) - Forecast 2024-2030

  • Report
  • 187 Pages
  • Global
From
Retinal Imaging Devices Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Retinal Imaging Devices Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 116 Pages
  • Global
From
The Retinal Atlas. Edition No. 2 - Product Image

The Retinal Atlas. Edition No. 2

  • Book
Ryan's Retina. 3 Volume Set. Edition No. 6 - Product Image

Ryan's Retina. 3 Volume Set. Edition No. 6

  • Book
Retinal Detachment Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Retinal Detachment Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 190 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.